Effects of α MAT Versus Steroid Injection in Knee Osteoarthritis (STα MAT-knee Study)

NCT04230902 PHASE3 UNKNOWN

Knee Osteoarthritis (OA) is a common degenerative knee condition of the knee which is treated symptomatically. Knee cartilage tissue has little regenerative ability With the developments in regenerative medicine, stem cells might also be used in knee OA. Recently, adipose tissue has been identified as means for autologous mesenchymal stem cells (aMAT) using non-enzymatic method. Lipogems® is FDA-approved closed-system and directly producing ready-to-use aMAT. Some observational studies showed its potential in knee chondropathy. With no clinical trial done as yet, the investigators will hereby study the comparative efficacy of corticosteroid (current practice) versus Lipogems® in patients with knee OA. The knee MRI changes, clinical and patient-based outcomes will compared between baseline and throughout till 6 months after treatment. This study aims to show the comparative efficacy of Lipogems® as compared to corticosteroid in knee OA patients and to demonstrate its cartilage regeneration potential, which will ultimately deter surgery.

Details

Lead sponsor	American University of Beirut Medical Center
Phase	PHASE3
Status	UNKNOWN
Enrolment	48
Start date	Mon Mar 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Mar 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Knee Osteoarthritis

Interventions

• Microfragmented Adipose Tissue Transplant
• Corticosteroid injection

Countries

Lebanon